Skip to main content

Wong Alvin F's Form 4 filing

Puma Biotechnology, Inc. (PBYI) · filed Jun 6, 2022

Accession no.
0001437749-22-014437
Filed
Jun 6, 2022
Trade date
Jun 2, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.13K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wong Alvin FCIK 0001868855Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2022Common StockSSaleDisposed−587$1.92−$1,127.0461,447Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)